Benzinga - by Lisa Levin, Benzinga Editor.
- Stifel raised the price target for Hersha Hospitality Trust (NYSE: HT) from $8.75 to $10. Stifel analyst Simon Yarmak downgraded the stock from Buy to Hold. Hersha Hospitality Trust shares fell 0.5% to $9.74 in pre-market trading.
- Citigroup increased Verizon Communications Inc. (NYSE: VZ) price target from $39 to $40. Citigroup analyst Michael Rollins upgraded the stock from Neutral to Buy. Verizon shares rose 0.6% to close at $33.55 on Monday.
- UBS boosted the price target for Oracle Corporation (NYSE: ORCL) from $120 to $140. UBS analyst Karl Keirstead upgraded the stock from Neutral to Buy. Oracle shares rose 0.7% to close at $116.84 on Monday.
- Jefferies cut the price target for Forward Air Corporation (NASDAQ: FWRD) from $110 to $85. Jefferies analyst Stephanie Moore upgraded the stock from Hold to Buy. Forward Air shares fell 0.5% to close at $70.89 on Monday.
- Piper Sandler slashed Celanese Corporation (NYSE: CE) price target from $120 to $112. Piper Sandler analyst Charles Neivert downgraded the stock from Neutral to Underweight. Celanese shares fell 1.6% to $119.65 in pre-market trading.
- Wells Fargo boosted Rockwell Automation, Inc. (NYSE: ROK) price target from $290 to $317. Wells Fargo analyst Joe O'Dea upgraded the stock from Underweight to Equal-Weight. Rockwell Automation shares rose 0.9% to $311.67 in pre-market trading.
- Morgan Stanley cut Farfetch Limited (NYSE: FTCH) price target from $20 to $5. Morgan Stanley analyst Lauren Schenk downgraded the stock from Overweight to Equal-Weight. Farfetch shares fell 3.8% to close at $2.82 on Monday.
- HC Wainwright & Co. boosted ImmunoGen, Inc. (NASDAQ: IMGN) price target from $26 to $27. HC Wainwright & Co. analyst Swayampakula Ramakanth maintained a Buy rating. ImmunoGen shares rose 3% to $16.01 in pre-market trading.
- Morgan Stanley lowered the price target for BeiGene, Ltd. (NASDAQ: BGNE) from $321 to $319. Morgan Stanley analyst Matthew Harrison maintained an Overweight rating. BeiGene shares rose 5.2% to $212.50 in pre-market trading.
- BMO Capital increased Hersha Hospitality Trust (NYSE: HT) price target from $7 to $10. BMO Capital analyst Ari Klein maintained a Market Perform rating. Hersha Hospitality Trust shares fell 0.5% to $9.74 in pre-market trading.
- Morgan Stanley cut Kymera Therapeutics, Inc. (NASDAQ: KYMR) price target from $39 to $37. Morgan Stanley analyst James Quigley maintained an Equal-Weight rating. Kymera Therapeutics shares rose 0.1% to close at $19.66 on Monday.
Check This Out: Best Buy, HP And 3 Stocks To Watch Heading Into Tuesday
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.